LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 30.90 | 27.76 | 1382 | 2032 | 0.6800 | 0.8793 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 32.60 | 27.76 | 129 | 2235 | 0.0577 | 0.2746 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 32.60 | 27.76 | 1160 | 2235 | 0.5188 | 0.8031 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 32.60 | 27.76 | 1442 | 2235 | 0.6449 | 0.8662 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 32.60 | 27.76 | 1467 | 2235 | 0.6561 | 0.8712 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 34.30 | 27.76 | 119 | 2449 | 0.0486 | 0.2526 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 34.30 | 27.76 | 1211 | 2449 | 0.4943 | 0.7935 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 34.30 | 27.76 | 1475 | 2449 | 0.6021 | 0.8490 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 34.30 | 27.76 | 1504 | 2449 | 0.6139 | 0.8546 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 36.01 | 27.76 | 162 | 2662 | 0.0608 | 0.3073 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 36.01 | 27.76 | 1318 | 2662 | 0.4949 | 0.7974 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 36.01 | 27.76 | 1510 | 2662 | 0.5670 | 0.8349 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 36.01 | 27.76 | 1554 | 2662 | 0.5836 | 0.8429 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 37.71 | 27.76 | 174 | 2877 | 0.0605 | 0.3154 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 37.71 | 27.76 | 1382 | 2877 | 0.4803 | 0.7925 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 37.71 | 27.76 | 1642 | 2877 | 0.5706 | 0.8392 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 37.71 | 27.76 | 1669 | 2877 | 0.5800 | 0.8437 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 39.41 | 27.76 | 196 | 3105 | 0.0631 | 0.3327 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 39.41 | 27.76 | 1417 | 3105 | 0.4563 | 0.7822 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 39.41 | 27.76 | 1717 | 3105 | 0.5529 | 0.8332 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 39.41 | 27.76 | 1744 | 3105 | 0.5616 | 0.8374 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 41.11 | 27.76 | 263 | 3331 | 0.0789 | 0.3848 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 41.11 | 27.76 | 1514 | 3331 | 0.4545 | 0.7842 | MN20160318_Q01 | K14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 41.11 | 27.76 | 1769 | 3331 | 0.5310 | 0.8249 | MN20160318_Q01 | N07 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.56234 | 41.11 | 27.76 | 1799 | 3331 | 0.5400 | 0.8293 | MN20160318_Q01 | N07 |